"10.1371_journal.pone.0065518","plos one","2013-06-14T00:00:00Z","Ian Catchpole; Volker Germaschewski; Jaimie Hoh Kam; Peter Lundh von Leithner; Susannah Ford; Gerald Gough; Peter Adamson; Philip Overend; Jan Hilpert; Francisco J LÃ³pez; Yin Shan Eric Ng; Pete Coffey; Glen Jeffery","Topical BioPharm Discovery Research and Development Unit, King of Prussia, Philadelphia, Pennsylvania, United States of America; Institute of Ophthalmology, University College London, London, United Kingdom; GSK Ophthalmology, King of Prussia, Philadelphia, Pennsylvania, United States of America; BioPharm Discovery Medicine, GlaxoSmithKline, Stevenage, Herts, United Kingdom","Conceived and designed the experiments: IC VG GG PA PC GJ FJL YSEN. Performed the experiments: JHK PLvL SF YSEN. Analyzed the data: IC VG JHK PLvL SF PO PC GJ FJL YSEN. Contributed reagents/materials/analysis tools: IC VG JHK PLvL SF JH PC GJ. Wrote the paper: IC VG SF GJ PC PO JH. Full statistical analysis of raw data: PO.","IC, VG, SF, GG, PA, PO, JH are or were during some stage of this work employed by GSK who funded this study. GSK owns intellectual property on anti-amyloid beta monoclonal antibodies. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","06","Ian Catchpole","IC",13,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
